Jessica Kim Cohen

Findings from the nationwide survey suggest interest in PGx while highlighting areas for UK policymakers to pay attention to, researchers said.

PCRX-201 became part of Pacira's portfolio in 2021, but was originally developed at Baylor and then by GQ Bio Therapeutics, which Pacira is acquiring.

Based on early Phase I/II data, investigators at Cincinnati Children's are enrolling more patients with a telomere biology disorder and bone marrow failure.

The first patient, who had xerostomia linked with Sjögren's disease, received the autologous cell therapy as part of a Phase 0 trial.

A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another focused on polyneuropathy.

Researchers will launch a randomized clinical trial to assess whether PGx-guided care helps keep patients out of the ER and reduces costs.

Researchers have been "making great inroads" in precision medicine, and a 15 percent cap on indirect costs could quash the momentum, experts worry.

Moncyte Health's test evaluates biological differences in how cholesterol is transported and processed in cells, which can influence drug response.

These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such programs are necessary.

The positive results from the second part of the EMBARK trial contrast with findings from one-year post treatment, which did not meet the primary endpoint.